|
Symbol
|
RMACHV | ACKUTQ | ACLATQ | ACRFTQ | RMBDRV | RMBDNV | ADTRTQ | ADZYTQ | RMAV6V |
|---|---|---|---|---|---|---|---|---|---|
| Nom | Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Multi Reverse Convertible | Reverse Convertible | Reverse Convertible | Worst of Callable Reverse Convertible | Multi Reverse Convertible | Multi Vonti |
|
Sous-jacent
|
ASML Hldg. N.V. / Novo Nordisk AS (B) / SAP SE | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | Amgen Inc. / Intuitive Surgical Inc. / Novo Nordisk AS (B) | ASML Hldg. N.V. / Novo Nordisk AS (B) | ASML Hldg. N.V. / Novo Nordisk AS (B) | Adidas AG / LVMH Moet Hennessy Louis Vuitton / Novo Nordisk AS (B) | Alcon / Novo Nordisk AS (B) / Roche AG | ASML Hldg. N.V. / Novo Nordisk AS (B) / Oracle Corp. |
|
Emetteur
|
|
|
|
|
|
|
|
|
|
|
Échéance
|
17.08.2026 | 17.03.2027 | 17.03.2027 | 14.04.2027 | 13.08.2027 | 13.08.2027 | 20.08.2029 | 08.09.2026 | 11.10.2028 |
| Ratio | - | - | - | - | - | - | - | - | - |
|
Prix d'exercise
|
680,30 | 362,782 | 337,827 | 324,534 | 217,13 | 217,13 | 274,41 | 205,558 | 242,47 |
| rendement max. p.a. | 187,54% | 35,52% | 28,08% | 18,29% | 9,23% | 7,27% | 9,91% | 20,44% | 12,26% |
| Demande | 47,000 | 77,28 | 80,36 | 92,71 | 100,30 | 100,00 | 97,79 | 94,36 | 88,90 |
| Offre | 47,800 | 78,28 | 81,36 | 93,71 | 101,30 | 100,80 | 98,59 | 95,16 | 89,90 |